CTN Accepted for SymBio’s Japan Phase 1 Trial of Rigosertib (SyB L-1101)

News   Sep 27, 2012

 
CTN Accepted for SymBio’s Japan Phase 1 Trial of Rigosertib (SyB L-1101)
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE